Christine Jenkins's Publications

About Christine Jenkins's Publications

Program Head, Respiratory
  • Professor of Respiratory Medicine, Faculty of Medicine, UNSW Sydney
  • Clinical Professor, Concord Clinical School, University of Sydney
  • AM,
  • MD,
  • FRACP,
  • FThor ,
  • Soc ,
  • FAAHMS

  • Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

    Internal Medicine Journal Date published:

  • Experience of acute noninvasive ventilation-insights from ‘Behind the Mask’: a qualitative study

    BMJ Supportive & Palliative Care Date published:

  • Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

    Clinical and Translational Allergy Date published:

  • Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

    Clinical & Experimental Allergy Date published:

  • Successes and challenges of COPD management in Australia: reflections on the past and future

    The Lancet Respiratory Medicine Date published:

  • Periostin levels and eosinophilic inflammation in poorly-controlled asthma

    BMC Pulmonary Medicine Date published:

  • AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation

    European Respiratory Journal Date published:

  • Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma?

    European Respiratory Review Date published:

  • Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations

    International Journal of Chronic Obstructive Pulmonary Disease Date published:

  • SPUTUM INFLAMMATORY PHENOTYPES IN SYMPTOMATIC ASTHMA AROUND AUSTRALIA

    Date published:

  • Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease

    BMC Pulmonary Medicine Date published:

  • Tuberculosis associates with both airflow obstruction and low lung function: BOLD results

    European Respiratory Journal Date published:

  • Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations

    Journal of Allergy and Clinical Immunology Date published:

  • Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D

    European Respiratory Journal Date published:

  • Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1β

    Respiratory Research Date published:

  • "it Must Be Doing Something": COPD Patients' Rationales For Using Combination Ics/laba Treatment

    Date published: